Received: 5 July 2020
Accepted: 17 August 2020
First Online: 24 August 2020
Ethics approval and consent to participate
: The present study was approved on 23 January 2020 by the ethical board of the Institution in which it was performed—Instituto Português de Oncologia de Lisboa Francisco Gentil (Lisbon, Portugal). The ethical committee did not present any reference number in the final appreciation that was sent by institutional email.The patient included in this study gave written informed consent.
: The patient had signed written informed consent for research purposes, including the clinical details and the included images.
: The authors declare no competing interests.